Correlation Between Ovid Therapeutics and Equillium
Can any of the company-specific risk be diversified away by investing in both Ovid Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ovid Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ovid Therapeutics and Equillium, you can compare the effects of market volatilities on Ovid Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ovid Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ovid Therapeutics and Equillium.
Diversification Opportunities for Ovid Therapeutics and Equillium
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Ovid and Equillium is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Ovid Therapeutics and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Ovid Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ovid Therapeutics are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Ovid Therapeutics i.e., Ovid Therapeutics and Equillium go up and down completely randomly.
Pair Corralation between Ovid Therapeutics and Equillium
Given the investment horizon of 90 days Ovid Therapeutics is expected to generate 0.51 times more return on investment than Equillium. However, Ovid Therapeutics is 1.96 times less risky than Equillium. It trades about 0.04 of its potential returns per unit of risk. Equillium is currently generating about -0.2 per unit of risk. If you would invest 305.00 in Ovid Therapeutics on February 20, 2024 and sell it today you would earn a total of 10.00 from holding Ovid Therapeutics or generate 3.28% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ovid Therapeutics vs. Equillium
Performance |
Timeline |
Ovid Therapeutics |
Equillium |
Ovid Therapeutics and Equillium Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ovid Therapeutics and Equillium
The main advantage of trading using opposite Ovid Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ovid Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.Ovid Therapeutics vs. International Growth Fund | Ovid Therapeutics vs. MIRA Pharmaceuticals Common | Ovid Therapeutics vs. Fidelity Water Sustainability | Ovid Therapeutics vs. Merck Company |
Equillium vs. International Growth Fund | Equillium vs. MIRA Pharmaceuticals Common | Equillium vs. Fidelity Water Sustainability | Equillium vs. Merck Company |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |